Heparin-releasable TFPI is not depleted after repeated injections of tinzaparin at therapeutic dose for up to 30 days.
Gouin-Thibault
I
I
Pautas
E
E
Depasse
F
F
Andreux
J P
JP
Siguret
V
V
D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006493:Heparin / Q000494:pharmacology; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D008074:Lipoproteins / Q000097:blood / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D013927:Thrombosis / Q000188:drug therapy; D000078222:Tinzaparin
D006495:Heparin, Low-Molecular-Weight; D008074:Lipoproteins; C051928:lipoprotein-associated coagulation inhibitor; D000078222:Tinzaparin; D006493:Heparin